Fig. 2
From: Assessment of interleukin 32 as a novel biomarker for non-alcoholic fatty liver disease
ROC curve analysis for the diagnostic performance of IL-32 for NAFLD detection
Fig. 2 | Egyptian Liver Journal
From: Assessment of interleukin 32 as a novel biomarker for non-alcoholic fatty liver disease
ROC curve analysis for the diagnostic performance of IL-32 for NAFLD detection